Maravai Lifesciences Director Resigns for New CFO Role
Company Announcements

Maravai Lifesciences Director Resigns for New CFO Role

An announcement from Maravai Lifesciences Holdings (MRVI) is now available.

Anat Ashkenazi, a director at Maravai LifeSciences Holdings, Inc., is set to resign from her position on the Board effective July 31, 2024, due to the time requirements of her upcoming role as CFO of Alphabet Inc. Her departure is amicable and not due to any disputes regarding the company’s operations, policies, or practices.

See more insights into MRVI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyCodexis licenses genomics life science enzyme portfolio to Alphazyme
TheFlyFoot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz
TheFlyIllumina upgraded, Fiserv initiated: Wall Street’s top analyst calls
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App